Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Organogenesis Hldgs Q3 Adj. EPS $0.18 Beats $0.06 Estimate, Sales $150.587M Beat $134.100M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:12pm
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.06 by 221.82 percent. This is a 77 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $150.587 million which beat the analyst consensus estimate of $134.100 million by 12.29 percent. This is a 30.74 percent increase over sales of $115.177 million the same period last year.

Posted In: ORGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist